Arthur A. Levin - 14 Jun 2021 Form 4 Insider Report for Avidity Biosciences, Inc. (RNA)

Role
Chief Scientific Officer
Signature
/s/ John W. Wallen III, Ph.D., J.D., Attorney-in-Fact
Issuer symbol
RNA
Transactions as of
14 Jun 2021
Net transactions value
-$961,989
Form type
4
Filing time
16 Jun 2021, 20:21:29 UTC
Previous filing
25 Jun 2021
Next filing
22 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNA Common Stock Sale $362,921 -14,003 -38% $25.92 23,019 14 Jun 2021 By charitable remainder trust F1
transaction RNA Common Stock Sale $599,067 -23,019 -100% $26.02 0 15 Jun 2021 By charitable remainder trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $25.70 to $26.06. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $25.62 to $26.47. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.